New approaches to maintenance therapy were investigated, such as the use of tamibarotene (formerly Am80), which showed a trend for improved efficacy in high-risk APL patients [ 110 ].
← all excerpts
Acute Promyelocytic Leukemia: A History over 60 Years-From the Most Malignant to the most Curable Form of Acute Leukemia.
1
—
—